Drug Discovery Research, Kyoto R&D Centre, Maruho Co., Ltd, Chudoji, Kyoto, Japan.
Immunology. 2009 Sep;128(1 Suppl):e849-57. doi: 10.1111/j.1365-2567.2009.03094.x. Epub 2009 Mar 23.
Recently air pollutants and irritants have been labelled as possible exogenous risk factors for allergic disorders. Although the underlying causes of allergic disorders such as atopic dermatitis and asthma remain unclear, the T helper type 2 (Th2) cell-mediated allergic inflammatory cascade may contribute to their pathogenesis. In the last decade, it has been documented that one of the candidates for triggering Th2 commitment is thymic stromal lymphopoietin (TSLP), the expression of which is up-regulated in the lesions of allergic patients. Here, we describe TSLP function in a fluorescein isothiocyanate (FITC) -induced contact hypersensitivity (CHS) model. A cytokine profile indicated that the model was dominantly mediated by the Th2 milieu. Interestingly, TSLP was increased in the skin during the sensitization phase when stimulated by a solvent, dibutyl phthalate (DBP), but not by FITC hapten or another solvent, acetone. Ear swelling in FITC-induced CHS was totally abrogated by removing DBP from the sensitization or elicitation phase, and was restored by complementary injection of TSLP. Inversely, the ear swelling was suppressed by injection of small interfering RNA against TSLP during the sensitization phase, which was concomitant with decreasing expression of interleukin-4 at the swollen skin site. Taken together, DBP-induced TSLP during the sensitization phase plays a role in establishing FITC-induced CHS and may be one of the causes of Th2 commitment in the model, suggesting that certain environmental toxins, such as DBP, may endow pro-allergic and atopic predisposition in humans or animals.
最近,空气污染物和刺激物已被标记为过敏症的可能外源性风险因素。尽管特应性皮炎和哮喘等过敏症的根本原因尚不清楚,但辅助性 T 细胞 2(Th2)细胞介导的过敏炎症级联反应可能有助于其发病机制。在过去的十年中,已经有文献记载,触发 Th2 细胞承诺的候选者之一是胸腺基质淋巴细胞生成素(TSLP),其在过敏患者的病变中表达上调。在这里,我们描述了 TSLP 在荧光素异硫氰酸酯(FITC)诱导的接触超敏反应(CHS)模型中的功能。细胞因子谱表明该模型主要由 Th2 环境介导。有趣的是,当用溶剂邻苯二甲酸二丁酯(DBP)刺激时,TSLP 在皮肤中在致敏阶段增加,但FITC 半抗原或另一种溶剂丙酮则不会。从致敏或激发阶段去除 DBP 可完全消除 FITC 诱导的 CHS 中的耳肿胀,并且通过互补注射 TSLP 可恢复。相反,在致敏阶段注射针对 TSLP 的小干扰 RNA 可抑制耳肿胀,同时在肿胀皮肤部位的白细胞介素-4 表达降低。综上所述,致敏阶段的 DBP 诱导的 TSLP 在建立 FITC 诱导的 CHS 中起作用,并且可能是模型中 Th2 承诺的原因之一,这表明某些环境毒素,如 DBP,可能赋予人类或动物对变应原的易感性和特应性倾向。